MEEDER ASSET MANAGEMENT INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$5,000
-16.7%
175
+2.9%
0.00%
Q2 2022$6,000
+20.0%
170
+25.0%
0.00%
Q1 2022$5,000
+66.7%
136
-23.2%
0.00%
Q3 2021$3,0000.0%177
+24.6%
0.00%
Q2 2021$3,000
+50.0%
142
+6.0%
0.00%
Q1 2021$2,0000.0%134
+24.1%
0.00%
Q4 2020$2,000
-33.3%
108
-22.9%
0.00%
Q3 2020$3,000
+50.0%
140
+72.8%
0.00%
Q2 2020$2,000
-50.0%
81
-69.9%
0.00%
Q1 2020$4,000
-75.0%
269
-67.0%
0.00%
-100.0%
Q4 2019$16,000
+6.7%
815
+11.2%
0.00%0.0%
Q3 2019$15,000
-94.0%
733
-93.8%
0.00%
-94.1%
Q2 2019$249,000
-21.0%
11,741
-23.7%
0.02%
-32.0%
Q1 2019$315,000
+242.4%
15,396
+232.5%
0.02%
+212.5%
Q4 2018$92,000
-99.9%
4,631
-55.8%
0.01%
-42.9%
Q2 2018$160,017,000
+290840.0%
10,486
+259.8%
0.01%
+180.0%
Q1 2018$55,000
+10.0%
2,914
+11.2%
0.01%
+25.0%
Q4 2017$50,000
+900.0%
2,620
+915.5%
0.00%
+300.0%
Q3 2017$5,000
-28.6%
258
-33.2%
0.00%0.0%
Q2 2017$7,000
+133.3%
386
+95.9%
0.00%
Q1 2017$3,0001970.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders